| Effect of ginger and chamomile on nausea and vomiting caused by chemotherapy in Iranian women with breast cancer F Sanaati, S Najafi, Z Kashaninia, M Sadeghi Asian Pacific Journal of Cancer Prevention 17 (8), 4125-4129, 2016 | 106 | 2016 |
| Gluten sensitive enteropathy in patients with iron deficiency anemia of unknown origin F Zamani, M Mohamadnejad, R Shakeri, A Amiri, S Najafi, ... World Journal of Gastroenterology: WJG 14 (48), 7381, 2008 | 95 | 2008 |
| Randomized study of the effect of dietary counseling during adjuvant chemotherapy on chemotherapy induced nausea and vomiting, and quality of life in patients with breast cancer S Najafi, S Haghighat, M Raji Lahiji, E RazmPoosh, M Chamari, ... Nutrition and cancer 71 (4), 575-584, 2019 | 55 | 2019 |
| Effects of dietary ginger (Zingiber Ofjicinale), cinnamon (Cinnamomum), synbiotic and antibiotic supplementation on performance of broilers S Najafi, K Taherpour J. Anim. Sci. Adv 4 (1), 658-667, 2014 | 55 | 2014 |
| Comparison of SF-6D and EQ-5D scores in patients with breast cancer M Yousefi, S Najafi, S Ghaffari, A Mahboub-Ahari, H Ghaderi Iranian Red Crescent Medical Journal 18 (5), 2016 | 31 | 2016 |
| The effect of dietary intervention along with nutritional education on reducing the gastrointestinal side effects caused by chemotherapy among women with breast cancer R Abdollahi, S Najafi, E Razmpoosh, RS Shoormasti, S Haghighat, ... Nutrition and cancer 71 (6), 922-930, 2019 | 29 | 2019 |
| Newly developed targeted therapies against the androgen receptor in triple-negative breast cancer: A review E Choupani, MM Gomari, S Zanganeh, S Nasseri, K Haji-Allahverdipoor, ... Pharmacological reviews 75 (2), 309-327, 2023 | 26 | 2023 |
| Taxane-based regimens as a risk factor for chemotherapy-induced amenorrhea S Najafi, GE Djavid, N Mehrdad, E Rajaii, N Alavi, A Olfatbakhsh, M Najafi, ... Menopause 18 (2), 208-212, 2011 | 24 | 2011 |
| Effects of synbiotic supplementation on serum adiponectin and inflammation status of overweight and obese breast cancer survivors: a randomized, triple-blind, placebo … M Raji Lahiji, M Zarrati, S Najafi, B Yazdani, E Cheshmazar, ... Supportive Care in Cancer 29, 4147-4157, 2021 | 22 | 2021 |
| The effect of synbiotic on glycemic profile and sex hormones in overweight and obese breast cancer survivors following a weight-loss diet: A randomized, triple-blind … MR Lahiji, S Najafi, L Janani, B Yazdani, E Razmpoosh, M Zarrati Clinical Nutrition 40 (2), 394-403, 2021 | 20 | 2021 |
| Transcatheter arterial chemoembolization therapy for patients with unresectable hepatocellular carcinoma K Firouznia, H Ghanaati, SM Alavian, P Azadeh, MN Toosi, AH Mirzaian, ... Hepatitis Monthly 14 (12), 2014 | 18 | 2014 |
| Prognostic factors influencing prognosis in early breast cancer patients S Najafi, M Sadeghi, F Abasvandi, MR Shajari, K Mohebi, H Ghandchi Menopause Review/Przegląd Menopauzalny 18 (2), 82-88, 2019 | 16 | 2019 |
| Efficacy and safety of proposed bevacizumab biosimilar BE1040V in patients with metastatic colorectal cancer: a phase III, randomized, double-blind, noninferiority clinical trial H Rezvani, SM Mortazavizadeh, A Allahyari, A Nekuee, SN Najafi, ... Clinical therapeutics 42 (5), 848-859, 2020 | 12 | 2020 |
| Sexual dysfunction in breast cancer: a case-control study M Ebrahimi, S Haghighat, N Mehrdad, A Olfatbakhsh, A Azin, S Najafi Archives of Breast Cancer, 15-20, 2015 | 11 | 2015 |
| Lithium and preventing chemotherapy-induced peripheral neuropathy in breast cancer patients: a placebo-controlled randomized clinical trial S Najafi, Z Heidarali, M Rajabi, Z Omidi, F Zayeri, M Salehi, S Haghighat Trials 22, 1-9, 2021 | 10 | 2021 |
| Phase II study of adjuvant docetaxel and carboplatin with/without doxorubicin and cyclophosphamide in triple negative breast cancer: a randomised controlled clinical trial S Najafi, M Payandeh, M Sadeghi, V Shafaei, F Shojaiyan, F Abbasvandi Contemporary Oncology/Współczesna Onkologia 21 (1), 83-89, 2017 | 9 | 2017 |
| Mapping catquest scores onto EQ-5D utility values in patients with cataract disease M Yousefi, B Sheikhrobat, S Najafi, S Ghaffari, H Ghaderi, ... Iranian Red Crescent Medical Journal 19 (5), e21928, 2016 | 9 | 2016 |
| Comparing the efficacy and side-effects of PDLASTA®(Pegfilgrastim) with PDGRASTIM®(Filgrastim) in breast cancer patients: a non-inferiority randomized clinical trial S Najafi, M Ansari, V Kaveh, S Haghighat BMC cancer 21, 1-12, 2021 | 8 | 2021 |
| Diagnostic relevance of interleukin-6 and tumor necrosis factor alpha in discriminating high risk and low risk groups in febrile patients with neutropenia. M Parsa, SN Najafi, NJ Jafari, M Mohraz, A Ghavamzadeh, B Bahar, ... | 8 | 2007 |
| Comparing efficacy and safety of P013, a proposed pertuzumab biosimilar, with the reference product in HER2-positive breast cancer patients: a randomized, phase III … A Allahyari, A Ehsanpour, B Najafi, N Ansarinejad, V Mehrzad, B Kalantari, ... BMC cancer 22 (1), 960, 2022 | 6 | 2022 |
